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c o n c i s e c o m m u n i c a t i o n
Reducing the Incidence
of Intraventricular Catheter–Related
Ventriculitis in the Neurology-
Neurosurgical Intensive Care Unit
at a Tertiary Care Center in St Louis,
Missouri: An 8-Year Follow-Up Study
Hitoshi Honda, MD; Jeffrey C. Jones, MD;
Martha C. Craighead, MBA, RN;
Michael N. Diringer, MD; Ralph G. Dacey, MD;
David K. Warren, MD, MPH
We reviewed the effect of 3 interventions to reduce the incidence
of intraventricular catheter–related ventriculitis, conducted at a ter-
tiary care center in St Louis, Missouri, during an 8-year period. The
incidence density of intraventricular catheter–related ventriculitis
decreased substantially after the implementation of standardized
management of intraventricular catheters.
Infect Control Hosp Epidemiol 2010; 31(10):1078-1081
Intraventricular catheters are widely used for diagnostic and
therapeutic purposes in patients with hydrocephalus and el-
evated intracranial pressure. Ventriculitis is a recognized com-
plication that results from the use of these catheters. The
incidence of intraventricular catheter–related ventriculitis
ranges from 0% to 22%, depending on the definition of ven-
triculitis.1-3 Risk factors for intraventricular catheter–related
ventriculitis include prolonged intraventricular catheteriza-
tion, leakage of cerebrospinal fluid (CSF), intracranial hem-
orrhage, a recent neurosurgical procedure, the insertion of
multiple catheters, and the lack of a strict protocol for drain
management.1,4,5
Appropriate management of intraventricular catheters is
essential to prevent intraventricular catheter–related ventri-
culitis. Despite the potential life-threatening consequences of
intraventricular catheter-related infections, the optimal man-
agement of these devices has not been well investigated.
We chronologically implemented 3 interventions to stan-
dardize management of intraventricular catheters in a single
neurology-neurosurgical intensive care unit (NNICU) and
observed a reduction in the incidence of intraventricular cath-
eter–related ventriculitis during an 8-year period.
methods
A before-after study was conducted during the period from
January 2001 through December 2008 in the 20-bed NNICU
at Barnes-Jewish Hospital, a 1,252-bed, academic, tertiary
care center in St Louis, Missouri. During the preintervention
period, the physicians who inserted the intraventricular cath-
eters adhered to maximal barrier precautions (ie, the use of
cap, mask, sterile gown, and sterile gloves) during the pro-
cedure. Catheters could be inserted in patients in the NNICU
at the bedside or in the operating room. A transparent, semi-
permeable dressing was applied as a cover to the intraven-
tricular catheter insertion site. This dressing was not changed
at a regular interval but only when it was soiled or became
loose, and then only by neurosurgery staff physicians, resi-
dents, or NNICU physicians. The patient’s scalp hair was
trimmed with a hair clipper prior to intraventricular catheter
placement. Povidone-iodine was applied to the insertion site
of the intraventricular catheter. Patients who underwent in-
traventricular catheterization received cefazolin as an anti-
microbial prophylaxis prior to the procedure.
During our 8-year study, 3 interventions were subsequently
implemented to standardize management of intraventricular
catheters. These interventions have continued to be used as
a standard protocol after their implementation in our study.
The first intervention required that all medical personnel in
the patient’s room or in the operating room who were not
directly involved in the placement of the intraventricular
catheter wear a mask and cap while the patient underwent
intraventricular catheterization. This intervention was intro-
duced in May 2002. In June 2004, a standardized dressing
protocol was implemented (ie, the second intervention). This
protocol was adapted from guidelines to prevent intravascular
catheter–related bloodstream infections6 and consisted of 3
components: (1) use of sterile gauze dressing with adhesive
tape to cover the catheter site, (2) changing of the intraven-
tricular catheter site dressing every 48 hours by NNICU
nurses who received standard training, and (3) documenta-
tion of the date and time of gauze-dressing change. The third
intervention was the use of a clindamycin- and rifampin-
impregnated intraventricular catheter (Bactiseal; Codman)
starting in October 2006.7
We defined each period of our study as follows: period 1
was the preintervention period (January 2001–April 2002);
period 2 started after additional precautions were initiated
for healthcare workers present during catheter insertion (May
2002–May 2004); period 3 started after the implementation
of a standardized protocol for dressing an intraventricular
catheter site (June 2004–September 2006); and period 4
started after the introduction of the antimicrobial-impreg-
nated catheter (October 2006–December 2008).
All patients who underwent intraventricular catheterization
were included in our study. Patients were excluded if they
were less than 18 years of age; if they had a preexisting di-
agnosis of meningitis, subdural empyema, and/or internalized
ventricular shunt infection; or if they had a positive culture
result from a CSF sample 5 or more days after intraventricular
catheter removal.8 Intraventricular catheter–related ventri-
intraventricular catheter–related ventriculitis 1079
table 1. Incidence of Intraventricular Catheter–Related Ventriculitis in a Neurology-Neurosurgical Intensive Care Unit
at a Tertiary Care Center in St Louis, Missouri, by Study Period
Study period No. of catheter-days
Mean device utilization rate,
per month Incidence density
Incidence ratio vs period 1
(95% CI)
Period 1 1,125 0.17 3.56 …
Period 2 1,826 0.17 3.29 0.92 (0.26–3.27)
Period 3 3,690 0.30 2.17 0.61 (0.18–2.02)
Period 4 3,457 0.23 0.87 0.24 (0.05–1.09)
note. Period 1 was the preintervention period (January 2001–April 2002); period 2 started after additional precautions were initiated
for healthcare workers present during catheter insertion (May 2002–May 2004); period 3 started after the implementation of a standardized
protocol for dressing an intraventricular catheter site (June 2004–September 2006); and period 4 started after the introduction of the
antimicrobial-impregnated catheter (October 2006–December 2008). The incidence density of intraventricular catheter–related ventriculitis
was defined as the number of infections per 1,000 catheter-days. CI, confidence interval.
figure 1. Incidence density (which was defined as the number of infections per 1,000 catheter-days) of intraventricular catheter–related
ventriculitis in a neurology-neurosurgical intensive care unit at a tertiary care center in St Louis, Missouri. ∗See Methods for the description
of interventions.
culitis was defined as the growth of a pathogen from a CSF
culture at least 48 hours after intraventricular catheter in-
sertion.8 If common skin flora were isolated from the CSF
culture (eg, coagulase-negative staphylococci or Corynebac-
terium, Bacillus, Micrococcus, or Propionibacterium species),
then one of the following criteria also had to be met for the
patient to receive a diagnosis of intraventricular catheter–re-
lated ventriculitis: a positive Gram stain result from the original
CSF sample, consistent with the organism cultured; a decreased
CSF glucose level (ie, less than 25 mg/dL); an increased CSF
protein level (ie, greater than 50 mg/dL); or CSF neutrophilic
pleocytosis (ie, white blood cell count greater than 10 cells/
mm3).8
The primary outcome was the incidence density of intra-
ventricular catheter–related ventriculitis, which was defined as
the number of infections per 1,000 catheter-days. The monthly
device utilization rates were defined as the number of catheter-
days per total number of patient-days per month. Patients who
did not meet the aforementioned criteria were excluded from
these calculations. The incidence ratios and 95% confidence
intervals were calculated by use of SPSS, version 15.0 (SPSS),
and Epi Info, version 3.5.1 (Centers for Disease Control and
Prevention). Our study was approved by the Washington Uni-
versity Human Research Protection Office.
results
During the 8-year study period, a total of 953 patients un-
derwent intraventricular catheterization. Of these 953 pa-
tients, 42 (4.4%) were excluded from our study because they
either were less than 18 years of age (4 patients), had ven-
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triculitis due to an internalized ventricular shunt infection
(14 patients), or received a diagnosis of preexisting meningitis
or subdural empyema (24 patients), thus leaving 911 patients
for our study (resulting in a total of 10,098 catheter-days).
Nontraumatic intracranial hemorrhage was the most com-
mon indication for intraventricular catheterization (657
[72.1%] of 911 patients). The number of catheter-days during
each intervention period is shown in Table 1 and Figure 1.
The mean monthly device utilization rate per period ranged
from 0.17 to 0.30 (Table 1). The overall incidence of intra-
ventricular catheter–related ventriculitis was 2.3% (21 of 911
patients). Of the 21 patients with intraventricular catheter–
related ventriculitis, 14 patients (66.6%) had intraventricular
catheter–related ventriculitis due to gram-positive bacteria—
with the most common being coagulase-negative staphylo-
cocci (9 patients) and Enterococcus faecalis (3 patients)—and
7 patients (33.3%) had intraventricular catheter–related ven-
triculitis due to gram-negative bacteria—with the most com-
mon being from the Enterobacteriaceae family (Klebsiella
pneumoniae [3 patients], Enterobacter species [2 patients], and
Escherichia coli [1 patient]). The incidence density for each
period is shown in Table 1. The incidence density was highest
during the preintervention period (ie, 3.56 infections per
1,000 catheter-days). Compared with the initial 16-month
preintervention period, the last 27 months of our study had
a 76% reduction in the incidence of intraventricular catheter–
related ventriculitis ( ).Pp .066
discussion
The incidence of intraventricular catheter–related ventriculitis
decreased by more than three-quarters after the implementa-
tion of multiple interventions, although, because of our small
sample size, this reduction did not reach statistical significance.
However, our findings suggest that the standardized manage-
ment of intraventricular catheters and the use of antimicrobial-
impregnated catheters led to a decrease in the incidence of
intraventricular catheter–related ventriculitis. We hypothesize
that the implementation of a standardized protocol for dressing
an intraventricular catheter site, adapted from guidelines to
prevent intravascular catheter–related bloodstream infections,6
was a key component in reducing the risk of intraventricular
catheter–related ventriculitis. A previous study showed that
strict adherence to infection prevention measures during dress-
ing changes of intraventricular catheter sites terminated an
outbreak of Pseudomonas aeruginosa ventriculitis in a neuro-
surgical intensive care unit.9 Similar to central venous catheters,
intraventricular catheters are inserted into a sterile anatomical
space and are used to obtain CSF samples. Bacterial coloni-
zation and local inoculation around the intraventricular cath-
eter site likely predisposes a patient to intraventricular catheter–
related ventriculitis. Thus, the aseptic insertion and care of an
intraventricular catheter are essential to preventing infection.
Our study also supports the use of antimicrobial-impregnated
intraventricular catheters as a potential means to reduce the
incidence of ventriculitis. A small, randomized, controlled trial
demonstrated that the use of antimicrobial-impregnated ex-
ternal ventricular drain catheters reduced the colonization rate
by 50%, compared with the use of nonimpregnated catheters.10
Ideal management of intraventricular catheters is evolving.
In our study, the baseline characteristics of the patients, the
frequency of manipulation of the intraventricular catheter,
prophylactic antimicrobial use, adherence to maximal barrier
precautions, and the “washout” period for each intervention
were not assessed. However, a multidisciplinary approach and
the use of methods similar to those applied to the prevention
of intravascular catheter–related infections appear to hold the
promise of preventing intraventricular device–related infec-
tions in critically ill patients and warrant further study.
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